STAT’s Kate Sheridan has updated our most popular STAT Report to date, this time with 2021 data. Having combed through private returns data for more than a dozen of the biggest names in biotech venture capital, she’s built profiles of these firms and their executives, explained the strategies and companies behind their performance, and ranked them based on who delivered the best returns to shareholders.
Featured companies include: - Aisling Capital
- Alta Partners
- ARCH Venture Partners
- Canaan Partners
- The Column Group
- Flagship Pioneering
- Lilly Asia Ventures
- Longitude Capital
- Mission BioCapital
- New Enterprise Associates
- OrbiMed
- Polaris Partners
- Sofinnova Investments
- SV Health Investor
- Third Rock Ventures
- Versant Ventures
- Vivo Capital
Get the report
About STAT Reports STAT Reports help business executives, researchers, consultants, and analysts navigate the ever-changing life sciences industry. Each report provides deep analysis of a particular issue in health care. Pick and purchase the reports that are most relevant to you. Learn More
Other topics include: | 
No comments